Glipizide NDC 68788-8138

Product information

Brand name (proprietary)

Glipizide

Generic name (nonproprietary)

glipizide

Active ingredients

Glipizide — 10 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Preferred Pharmaceuticals Inc..

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 074223

Marketing start

Feb 11, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Sulfonylurea Compounds (Chemical structure)

Identifiers

Product ID 68788-8138_a2c8fccf-2431-4e3e-ba37-920df8ea189bSPL ID a2c8fccf-2431-4e3e-ba37-920df8ea189bSPL set ID 02857195-33e9-4c1f-9e5f-7cc62f283649RxCUI 310488UNII X7WDT95N5C

Pharmacologic class

Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788813801 followed by a unit qualifier and the quantity Copy

Package 68788-8138-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 074223

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.